KRYSTAL-12: phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation - Mok, T SK; Yao, W; Duruisseaux, M (J Clin Oncol, 2024)